Yasuyuki Higashi
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Impacts of dosing and drug withdrawal period on tacrolimus-based triple therapy in a non-human primate renal transplantation model.
Journal: Transplant immunology
Published: April 26, 2022
Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
Journal: European journal of pharmacology
Published: June 21, 2019
Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor.
Journal: Bioorganic & medicinal chemistry
Published: July 20, 2018
Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model.
Journal: European journal of pharmacology
Published: June 22, 2018
Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: July 07, 2017
Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
Journal: Bioorganic & medicinal chemistry
Published: April 04, 2017
Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
Journal: Bioorganic & medicinal chemistry
Published: August 22, 2016
A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model.
Journal: Journal of pharmacological sciences
Published: July 19, 2016
Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys.
Journal: International immunopharmacology
Published: June 18, 2016
Inhibition of c-Rel DNA binding is critical for the anti-inflammatory effects of novel PIKfyve inhibitor.
Journal: European journal of pharmacology
Published: January 07, 2016
Last Updated: 09/26/2026